Vanishing Workforce: An Antimicrobial Resistance Threat

This month, world leaders will gather at the UN General Assembly to address the looming threat of antimicrobial resistance (AMR). They will discuss antimicrobial access, governance, coordination, and many other critical aspects of the fight against AMR. Yet there’s one critical component to any successful outcome that is overlooked and underfunded: the dwindling antimicrobial research […]

What Happens When the Last AMR Researcher Turns Off the Lights in the Lab?

Much of modern medicine is possible because of antibiotics. Orthopedic surgeries, caesarean deliveries, and heart and kidney transplants are made safer by antibiotics. Patients who are immunocompromised rely on antibiotics to avoid devastating infections, and those with uncomplicated cystitis, pneumonia and cellulitis feel better after a single course of these amazing products.

UK’s NHS to require companies to meet responsible antibiotic manufacturing standard

The United Kingdom’s National Health Service (NHS) announced yesterday that pharmaceutical companies applying for a contract through its antibiotic subscription model will have to prove they are meeting responsible antibiotic manufacturing standards. The first-of-its kind NHS Antimicrobial Product Subscription Model pays companies a fixed annual fee for antibiotics based on their value to the NHS […]

Belgium Developing New Class of Antibiotics, But Incentives and Market Support Needed

Europe’s pipeline of new antibiotics to tackle the growing antimicrobial resistance (AMR) crisis remains inadequate. Belgium is developing a new antibiotic class, but success depends on securing vital support and incentives.  A recent report by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reveals that between 2017 and 2023, only ten gained approval, with […]